DE2264723C2 - Verfahren zur Herstellung von Salzen des 4,4'-(2-Pyridylmethylen)-bis-(phenylhydrogensulfats) - Google Patents
Verfahren zur Herstellung von Salzen des 4,4'-(2-Pyridylmethylen)-bis-(phenylhydrogensulfats)Info
- Publication number
- DE2264723C2 DE2264723C2 DE2264723A DE2264723A DE2264723C2 DE 2264723 C2 DE2264723 C2 DE 2264723C2 DE 2264723 A DE2264723 A DE 2264723A DE 2264723 A DE2264723 A DE 2264723A DE 2264723 C2 DE2264723 C2 DE 2264723C2
- Authority
- DE
- Germany
- Prior art keywords
- general formula
- bis
- pyridylmethylene
- compound
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 19
- 150000003839 salts Chemical class 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title claims description 6
- UJIDKYTZIQTXPM-UHFFFAOYSA-N [4-[pyridin-2-yl-(4-sulfooxyphenyl)methyl]phenyl] hydrogen sulfate Chemical class C1=CC(OS(=O)(=O)O)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS(O)(=O)=O)C=C1 UJIDKYTZIQTXPM-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 24
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 241000251730 Chondrichthyes Species 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- -1 alkaline earth metal cation Chemical class 0.000 description 5
- 150000007530 organic bases Chemical group 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 229910000838 Al alloy Inorganic materials 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 4
- 239000012736 aqueous medium Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- OQFKODRWEHYZQP-UHFFFAOYSA-N (4-methoxyphenyl)-pyridin-2-ylmethanol Chemical compound C1=CC(OC)=CC=C1C(O)C1=CC=CC=N1 OQFKODRWEHYZQP-UHFFFAOYSA-N 0.000 description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000005695 dehalogenation reaction Methods 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 2
- XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical compound OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 description 2
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 229940125722 laxative agent Drugs 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- QJPJQTDYNZXKQF-UHFFFAOYSA-N 4-bromoanisole Chemical compound COC1=CC=C(Br)C=C1 QJPJQTDYNZXKQF-UHFFFAOYSA-N 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910000990 Ni alloy Inorganic materials 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- CTYRPMDGLDAWRQ-UHFFFAOYSA-N phenyl hydrogen sulfate Chemical compound OS(=O)(=O)OC1=CC=CC=C1 CTYRPMDGLDAWRQ-UHFFFAOYSA-N 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4343171 | 1971-09-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2264723A1 DE2264723A1 (de) | 1974-10-03 |
| DE2264723C2 true DE2264723C2 (de) | 1982-12-23 |
Family
ID=10428727
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2264723A Expired DE2264723C2 (de) | 1971-09-17 | 1972-09-11 | Verfahren zur Herstellung von Salzen des 4,4'-(2-Pyridylmethylen)-bis-(phenylhydrogensulfats) |
| DE2244461A Expired DE2244461C3 (de) | 1971-09-17 | 1972-09-11 | 3-Chlor-4,4'-disulfoxydiphenyl-(2-pvridyl)-methansalze, Verfahren zu deren Herstellung sowie diese Salze enthaltende pharmazeutische Zusammensetzungen |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2244461A Expired DE2244461C3 (de) | 1971-09-17 | 1972-09-11 | 3-Chlor-4,4'-disulfoxydiphenyl-(2-pvridyl)-methansalze, Verfahren zu deren Herstellung sowie diese Salze enthaltende pharmazeutische Zusammensetzungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3822273A (en:Method) |
| BE (1) | BE788613A (en:Method) |
| DE (2) | DE2264723C2 (en:Method) |
| DK (1) | DK138986B (en:Method) |
| FR (1) | FR2154509B1 (en:Method) |
| GB (1) | GB1345215A (en:Method) |
| LU (1) | LU66091A1 (en:Method) |
| SE (1) | SE410967B (en:Method) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH513167A (it) * | 1966-12-14 | 1971-09-30 | Angeli Inst Spa | Procedimento di preparazione di sali de 4,4'-disolfossi-difenil-(2-piridil)-metano |
| US3558643A (en) * | 1966-12-14 | 1971-01-26 | Angeli Inst Spa | Certain 4,4'-dioxy-diphenyl-(2-pyridyl)-methanes |
-
0
- BE BE788613D patent/BE788613A/xx not_active IP Right Cessation
-
1971
- 1971-07-17 GB GB4343171*A patent/GB1345215A/en not_active Expired
-
1972
- 1972-09-11 DE DE2264723A patent/DE2264723C2/de not_active Expired
- 1972-09-11 US US00288076A patent/US3822273A/en not_active Expired - Lifetime
- 1972-09-11 DE DE2244461A patent/DE2244461C3/de not_active Expired
- 1972-09-14 FR FR7232559A patent/FR2154509B1/fr not_active Expired
- 1972-09-15 SE SE7211944A patent/SE410967B/xx unknown
- 1972-09-15 LU LU66091A patent/LU66091A1/xx unknown
- 1972-09-15 DK DK458472AA patent/DK138986B/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2264723A1 (de) | 1974-10-03 |
| SE410967B (sv) | 1979-11-19 |
| GB1345215A (en) | 1974-01-30 |
| LU66091A1 (en:Method) | 1973-01-17 |
| DE2244461B2 (de) | 1977-10-06 |
| DE2244461C3 (de) | 1980-02-21 |
| DK138986C (en:Method) | 1979-05-07 |
| FR2154509A1 (en:Method) | 1973-05-11 |
| DK138986B (da) | 1978-11-27 |
| DE2244461A1 (de) | 1973-04-12 |
| BE788613A (fr) | 1973-01-02 |
| FR2154509B1 (en:Method) | 1976-04-23 |
| US3822273A (en) | 1974-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1804691C3 (de) | Taurocholensäurederivate | |
| DE3048167A1 (de) | Xanthen-verbindungen | |
| DE2264723C2 (de) | Verfahren zur Herstellung von Salzen des 4,4'-(2-Pyridylmethylen)-bis-(phenylhydrogensulfats) | |
| DE2948142C2 (de) | Verfahren zur Herstellung von 21-Acylthio-Steroiden | |
| DE1962757B2 (de) | Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
| DE2900630A1 (de) | Verfahren zur herstellung von alkoxy- substituierten polycyclischen aromatischen verbindungen | |
| DE830511C (de) | Verfahren zur Herstellung von neuen diquartaeren Salzen von Pyrimidylaminochinolinen | |
| DE2440233C2 (de) | Verfahren zur Herstellung von 3,3'-Thiobis[2-methoxy-1-azabenzanthron] | |
| DE1670583A1 (de) | Neue Piperidinderivate | |
| DE1468517B1 (de) | Steroide der OEstranreihe und Verfahren zu deren Herstellung | |
| AT265243B (de) | Verfahren zur Herstellung von neuen Salzen der p-Chlorphenoxyisobuttersäure | |
| DE2412323C3 (de) | 1,2-Diphenyl-äthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE2038836A1 (de) | Arzneimittel | |
| DE890648C (de) | Verfahren zur Herstellung von MonoalkylihydraziinsuMaten | |
| DE2129887A1 (de) | 2,4,6-trijodbenzoesaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung als roentgenkontrastmittel | |
| AT257612B (de) | Verfahren zur Herstellung von Sulfonamiden | |
| DE1470243C (de) | Ergolin-I-derivate und ein Verfahren zu ihrer Herstellung | |
| DE1468517C (de) | Steroide der Ostranreihe und Ver fahren zu deren Herstellung | |
| DE653008C (de) | Verfahren zur Herstellung von Aminosulfonen | |
| DE2215896C3 (de) | Verfahren zur Herstellung von 5-Fluor-uracil | |
| DE1795683C3 (de) | Verfahren zur Herstellung von Dialkalimetallsalzen des Bis-(4-sulfoxyphenyl) - (2-pyridyl) -methane | |
| DE1470424C (de) | Verfahren zur Herstellung von 3-Alkylthiazolidin-4-onen | |
| DE1003737B (de) | Verfahren zur Herstellung des 2-(p-Aminobenzolsulfonylamino)-4, 5-dimethyl-oxazols | |
| DE266788C (en:Method) | ||
| AT307446B (de) | Verfahren zur Herstellung von Glucofuranosiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AC | Divided out of |
Ref country code: DE Ref document number: 2244461 Format of ref document f/p: P |
|
| D2 | Grant after examination | ||
| 8339 | Ceased/non-payment of the annual fee |